ConductScience.org, home

Paper2448

Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.

Lüllmann H and 2 others. CRC Crit Rev Toxicol, 1975. Cited by 208 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine. Papers, record 2448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2448

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.
PubMed
Journal
CRC Crit Rev Toxicol
PubMed
Year
1975
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
208
iCite
Relative citation ratio, by iCite
9.07
iCite
Revised in PubMed
2019-10-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lüllmann HH
2Lüllmann-Rauch RR
3Wassermann OO

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PhospholipidsMajor topic
Animals
Antidepressive Agents, Tricyclic
Chemical Phenomena
Chemistry
Chloroquine
Chlorphentermine
Cholesterol
Depression, Chemical
Drug Evaluation, Preclinical
Guinea Pigs
Piperazine
Piperazines
Rats
Surface-Active Agents
Tranquilizing Agents
Vasodilator Agents

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 208 citations.

PMIDTitleJournalYearIn PapersSource
41369775New approach methodologies for metabolic disruption: a high-throughput human liver cell phospholipidosis assay.Arch Toxicol2026https://conductscience.org/library/papers/41369775PubMed
40241898Amiodarone-related keratopathy and optic neuropathy: case report and literature review.Front Med (Lausanne)2025https://conductscience.org/library/papers/40241898PubMed
38370571Hydroxychloroquine-Induced Renal Phospholipidosis: Case Report and Review of Differential Diagnoses.Case Rep Nephrol Dial2024https://conductscience.org/library/papers/38370571PubMed
38134445AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis.Mol Pharm2024https://conductscience.org/library/papers/38134445PubMed
33306921Tafenoquine: a toxicity overview.Expert Opin Drug Saf2021https://conductscience.org/library/papers/33306921PubMed
33126762Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation.Molecules2020https://conductscience.org/library/papers/33126762PubMed
26544718Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats.Med Princ Pract2016https://conductscience.org/library/papers/26544718PubMed
24980264Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.Toxicol Sci2014https://conductscience.org/library/papers/24980264PubMed
24791065Pathology and Neurotoxicity in Dogs after Repeat Dose Exposure to a Serotonin 5-HT1B Inhibitor.J Toxicol Pathol2014https://conductscience.org/library/papers/24791065PubMed
22945602Identification of drugs inducing phospholipidosis by novel in vitro data.ChemMedChem2012https://conductscience.org/library/papers/22945602PubMed
22449202Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.Mol Pharm2012https://conductscience.org/library/papers/22449202PubMed
21976946Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer.Korean J Ophthalmol2011https://conductscience.org/library/papers/21976946PubMed
21779761Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.Pflugers Arch2011https://conductscience.org/library/papers/21779761PubMed
18604229Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues.Br J Pharmacol2008https://conductscience.org/library/papers/18604229PubMed
10826129The anomalous pharmacokinetics of amiodarone explained by nonexponential tissue trapping.J Pharmacokinet Biopharm1999https://conductscience.org/library/papers/10826129PubMed
8858564Regulation of cardiolipin biosynthesis in the heart.Mol Cell Biochem1996https://conductscience.org/library/papers/8858564PubMed
7495377Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite.Arch Toxicol1995https://conductscience.org/library/papers/7495377PubMed
7469944Experimental lipidosis of the inner ear.Arch Otorhinolaryngol1980https://conductscience.org/library/papers/7469944PubMed
7225310Tamoxifen retinopathy.Br J Ophthalmol1981https://conductscience.org/library/papers/7225310PubMed
7167207Adrenocortical function of rats under prolonged administration of lipidosis-inducing drugs.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/7167207PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2448

GET https://conductscience.org/api/papers/v1/2448/cited_by?page=2